首页> 外文OA文献 >Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress
【2h】

Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress

机译:环氧合酶-2抑制改善内毒素休克大鼠模型中的血管内皮功能障碍:iNOS和氧化应激的作用

摘要

We investigated whether cyclooxygenase (COX) isoforms (COX-1 and COX-2) and decreased NO availability contribute to endothelial dysfunction in endotoxemic rats. The involvement of reactive oxygen species (ROS) was also evaluated. Rats were injected with Salmonella-derived lipopolysaccharide or saline. After 6 h, endothelial function of mesenteric resistance arteries was evaluated. In controls, acetylcholine (ACh)-induced relaxation was inhibited by the nitric-oxide synthase inhibitor N(G)-monomethyl-l-arginine (l-NMMA) and unaffected by 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2(5H)-furanone (DFU) (COX-2 inhibitor). In lipopolysaccharide (LPS)-treated rats, the response to ACh was blunted compared with controls, less sensitive to l-NMMA, and enhanced by DFU. COX-2 blockade also improved the inhibitory effect of l-NMMA on cholinergic relaxation. SC-560 [5-(4-clorophenyl)-1-(4-metoxyphenyl)-3-trifluoromethylpirazole] (COX-1 inhibitor) did not modify the response to ACh in both groups. LPS-induced endothelial dysfunction was unaffected by the thromboxane A(2) (TxA(2)) receptor antagonist SQ-29548 (7-[3-[[2-[(phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1] hept-2-yl]-[1S(1alpha,2alpha(Z),3alpha,4alpha)]-5-heptenoic acid). In vivo inducible nitric-oxide synthase (iNOS) inhibition by S-methylisothiourea partly attenuated LPS-induced endothelial dysfunction. The antioxidants ascorbic acid and superoxide dismutase normalized endothelium-dependent relaxation and restored the inhibitory action of l-NMMA on ACh. Responses to sodium nitroprusside were similar in both groups. In LPS-treated rats, reverse transcription-polymerase chain reaction showed a marked increase in mesenteric iNOS and COX-2 expressions, whereas endothelial nitric-oxide synthase and COX-1 were unchanged. LPS-induced COX-2 overexpression was reduced but not abrogated by S-methylisothiourea. LPS-induced COX-2 up-regulation was also documented by immunohistochemistry. In conclusion, mesenteric resistance vessels from endotoxemic rats show impaired endothelial function due to reduced NO availability, a condition that is partly ascribable to an iNOS-dependent enhanced COX-2 expression, whereas TxA(2) does not seem to be involved. Oxidative stress is the main mechanism responsible for reduced NO availability, and COX-2 might act as a source of ROS.
机译:我们调查了环氧合酶(COX)同工型(COX-1和COX-2)和减少的NO利用率是否有助于内毒素血症大鼠的内皮功能障碍。还评估了活性氧(ROS)的参与。给大鼠注射沙门氏菌衍生的脂多糖或盐水。 6小时后,评估肠系膜阻力动脉的内皮功能。在对照组中,一氧化氮合酶抑制剂N(G)-单甲基-1-精氨酸(1-NMMA)抑制了乙酰胆碱(ACh)诱导的松弛,并且不受5,5-二甲基-3-(3-氟苯基)的影响-4-(4-甲基磺酰基)-苯基-2(5H)-呋喃酮(DFU)(COX-2抑制剂)。在脂多糖(LPS)处理的大鼠中,与对照组相比,对ACh的反应减弱,对1-NMMA的敏感性降低,并被DFU增强。 COX-2阻断剂还改善了1-NMMA对胆碱能松弛的抑制作用。 SC-560 [5-(4-氯苯基)-1-(4-甲氧基苯基)-3-三氟甲基吡唑](COX-1抑制剂)两组均未改变对ACh的反应。 LPS诱导的内皮功能障碍不受血栓烷A(2)(TxA(2))受体拮抗剂SQ-29548(7- [3-[[2-[([苯基氨基)羰基]肼基]甲基] -7-氧杂双环[ 2.2.1]庚-2-基]-[1S(1α,2α(Z),3α,4α)]-5-庚烯酸)。 S-甲基异硫脲的体内诱导型一氧化氮合酶(iNOS)抑制可部分减轻LPS诱导的内皮功能障碍。抗氧化剂抗坏血酸和超氧化物歧化酶使内皮依赖性舒张正常化,并恢复了l-NMMA对ACh的抑制作用。两组对硝普钠的反应相似。在接受LPS治疗的大鼠中,逆转录聚合酶链反应显示肠系膜iNOS和COX-2表达显着增加,而内皮型一氧化氮合酶和COX-1不变。 LPS诱导的COX-2过表达减少,但S-甲基异硫脲未消除。免疫组织化学也证实了LPS诱导的COX-2上调。总之,来自内毒素血症大鼠的肠系膜阻力血管由于NO利用率降低而显示出内皮功能受损,这种情况部分归因于iNOS依赖性COX-2表达增强,而TxA(2)似乎没有参与。氧化应激是导致NO利用率降低的主要机制,COX-2可能是ROS的来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号